Category - Executive Moves

Executive Moves

Therma Bright adds pharma veteran Douglas S. Sommerville to AB

Therma Bright (TSXV: THRM; OTCQB: TBRIF), has announced the addition of Douglas S. Sommerville to its advisory board. In a statement, Rob Fia, CEO of Therma Bright, said, “Doug is highly respected across North...

September 12, 2024

Executive Moves

Creyon Bio appoints venture capitalists Serge Messerlian and Shaquille Vayda to board

Creyon Bio has appointed two prominent venture capitalists, Serge Messerlian, operating partner at DCVC Bio, and Shaquille Vayda, principal at Lux Capital, to its board. “We are excited to welcome Serge and Shaq...

September 10, 2024

Executive Moves

MOBILion appoints Rohit Khanna to BOD

Closely-held MOBILion Systems has announced the appointment of seasoned life sciences executive, Rohit Khanna, Ph.D., to its board, effective immediately. Dr. Khanna co-founded software engineering firm Dynamic...

August 28, 2024

Executive Moves

ANEW Medical appoints Jeffrey LeBlanc as CFO

ANEW Medical (NASDAQ:WENA) announced the appointment of Jeffrey LeBlanc as its new CFO, succeeding interim CFO, Edward Cong Wang, the former CFO of Redwoods Acquisition, which ANEW merged with. ANEW’s portfolio includes...

August 19, 2024

Executive Moves

Carisma Therapeutics expands SAB with renowned KOLs

Carisma Therapeutics (NASDAQ:CARM) has appointed Drs. Scott Friedman and Ira Tabas to its scientific advisory board (SAB). “It is an honor to welcome Dr. Friedman and Dr. Tabas to our SAB,” said Steven...

August 6, 2024

Executive Moves

Cantargia names Ton Berkien as CBO

Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) announced the recruitment of Ton Berkien as Chief Business Officer effective October 1. Mr. Berkien joins the management team at Cantargia with approximately 30 years of...

June 11, 2024

Executive Moves

Sigyn Therapeutics names Jerry DeCiccio as CFO

Sigyn Therapeutics (OTCQB:SIGY) appointed Jerry DeCiccio as CFO, succeeding Jeremy Farrell, who was appointed CFO in March of 2022. Mr. DeCiccio has more than 40 years of financial industry experience, previously...

December 12, 2023

Executive Moves

SAB Biotherapeutics names Michael G. King Jr. as CFO

SAB Biotherapeutics (NASDAQ:SABS) appointed Michael G. King Jr. as CFO, effective Oct 30. Mr. King replaces Russell Beyer, who is expected to step down on Nov. 15 and remain a senior advisor with the company for the...

October 25, 2023

Executive Moves

Mati promotes Chris Muller to COO

Closely-held Mati Therapeutics named Chris Muller as COO, effective immediately. Most recently Mati’s CCO, Mr. Muller’s expanded responsibilities include overseeing all operating activities; and preparing for and...

September 28, 2023

Executive Moves

Aurinia appoints Hepion’s Dr. Robert T. Foster to board

Aurinia Pharmaceuticals (NASDAQ:AUPH) appointed Dr. Robert T. Foster, CEO of Hepion Pharmaceuticals, to its board. “As the doctor who discovered voclosporin, and Aurinia’s founder, [Dr. Foster] has a wealth of...

September 21, 2023

Category - Executive Moves

Subscribe